China’s Central Committee and State Council Outline Reforms for Elderly Care Services
The Communist Party of China (CPC) Central Committee and State Council have released the Opinions...
Policy / Regulatory
Shanghai Opens Door to Wholly Foreign-Owned Hospitals in Key Areas
The Shanghai Municipal Health Commission, along with three other bureaus, has jointly released the “Work...
NHSA Strengthens Medical Security Rights for Workers in China
China’s National Healthcare Security Administration (NHSA) has released the “Notice on Further Strengthening the Protection...
NMPA Releases 88th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 88th batch of reference drugs for...
CDE Announces 90th Batch of Reference Preparations for GQCE
China’s Center for Drug Evaluation (CDE) has selected the 90th batch of reference preparations for...
China’s Healthcare Bureaus Remove Drug Quantity Limits to Enhance NRDL Access
The healthcare security administration bureaus in Shanghai, Beijing, and other regions have recently removed limits...
China’s State Council Aims to Enhance Drug and Medical Device Regulation by 2027
China’s State Council has released the “Opinions on Fully Deepening the Reform of Drug and...
Shanghai Enacts New Regulations for Drug and Medical Device Administration
The Standing Committee of the Shanghai Municipal People’s Congress has approved and released the “Regulations...
10th National VBP Round Results Announced: Contracts Worth Over RMB1.3 Billion
The national Volume-Based Procurement (VBP) authorities have released comprehensive details regarding the 10th VBP round,...
NMPA Releases 87th Batch of Reference Drugs for Generic Quality Consistency
The National Medical Products Administration (NMPA) has released the 87th batch of reference drugs for...
Hainan Free Trade Port Gets Green Light for Temporary Import of Special Medical Foods
The State Administration for Market Regulation (SAMR) in China has given its approval in principle...
Beijing Releases List of Novel Drugs and Technologies Exempt from CHS-DRG Payment Scheme
The Beijing Municipal Medical Insurance Bureau has released the list of the first batch of...
NMPA’s CDE Releases Draft Proposal for Benefit-Risk Assessment in Global Drug Development
The Center for Drug Evaluation of the National Medical Products Administration (NMPA) has issued the...
Guangdong Province Releases List of Urgent Clinical Drugs and Devices for GBA Cities
The medical products administration and health commission of Guangdong province have released a list of...
Beijing Conference Outlines 2025 Healthcare Security Goals and 2024 Progress
A national conference on healthcare security was recently held in Beijing, reviewing the achievements of...
National VBP Program Round 10: 195 Manufacturers Secure Winning Bids for 62 Drugs
The preliminary outcomes of the 10th round of China’s national volume-based procurement (VBP) program were...
Shanghai Unveils Action Plan and Fund for Biopharma M&A Activities
The Shanghai Municipal People’s Government has released the “Action Plan for Supporting Mergers and Acquisitions...
Beijing Expands Medical Insurance Sharing to Near Relatives with New Policy
The Beijing Municipal Medical Insurance Bureau has released a notification that significantly expands the scope...
CDE Releases 89th Batch of Reference Preparations for Generic Quality Consistency
The Center for Drug Evaluation (CDE) in China has announced the selection of the 89th...
NMPA Proposes Draft for Simplified Registration of Traditional Chinese Medicines from Hong Kong and Macao
The National Medical Products Administration (NMPA) has issued the “Notification on Simplifying the Registration and...